227 related articles for article (PubMed ID: 22613268)
1. Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by (1)H nuclear magnetic resonance-based metabonomic profiles.
Zhang L; Jin H; Guo X; Yang Z; Zhao L; Tang S; Mo P; Wu K; Nie Y; Pan Y; Fan D
Clin Biochem; 2012 Sep; 45(13-14):1064-9. PubMed ID: 22613268
[TBL] [Abstract][Full Text] [Related]
2. Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients.
Sun L; Hu W; Liu Q; Hao Q; Sun B; Zhang Q; Mao S; Qiao J; Yan X
J Proteome Res; 2012 May; 11(5):2937-46. PubMed ID: 22428626
[TBL] [Abstract][Full Text] [Related]
3. A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
Kobayashi T; Nishiumi S; Ikeda A; Yoshie T; Sakai A; Matsubara A; Izumi Y; Tsumura H; Tsuda M; Nishisaki H; Hayashi N; Kawano S; Fujiwara Y; Minami H; Takenawa T; Azuma T; Yoshida M
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):571-9. PubMed ID: 23542803
[TBL] [Abstract][Full Text] [Related]
4. 1H NMR-based metabonomic study on the metabolic changes in the plasma of patients with functional dyspepsia and the effect of acupuncture.
Wu Q; Zhang Q; Sun B; Yan X; Tang Y; Qiao X; Chen Q; Yu S; Liang F
J Pharm Biomed Anal; 2010 Feb; 51(3):698-704. PubMed ID: 19854601
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic profiling of serum from human pancreatic cancer patients using 1H NMR spectroscopy and principal component analysis.
OuYang D; Xu J; Huang H; Chen Z
Appl Biochem Biotechnol; 2011 Sep; 165(1):148-54. PubMed ID: 21505807
[TBL] [Abstract][Full Text] [Related]
6. ¹H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus.
Ouyang X; Dai Y; Wen JL; Wang LX
Lupus; 2011 Nov; 20(13):1411-20. PubMed ID: 21976403
[TBL] [Abstract][Full Text] [Related]
7. Utility of nuclear magnetic resonance spectroscopy for pancreatic cancer studies.
Tesiram YA; Lerner M; Stewart C; Njoku C; Brackett DJ
Pancreas; 2012 Apr; 41(3):474-80. PubMed ID: 22422139
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic characterization of human pancreatitis by ¹H-NMR spectroscopy.
Ouyang D
Hepatogastroenterology; 2012 Oct; 59(119):2314-7. PubMed ID: 22328301
[TBL] [Abstract][Full Text] [Related]
9. An insight into the metabolic responses of ultra-small superparamagnetic particles of iron oxide using metabonomic analysis of biofluids.
Feng J; Liu H; Zhang L; Bhakoo K; Lu L
Nanotechnology; 2010 Oct; 21(39):395101. PubMed ID: 20820093
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol metabolism is modulated by quercetin in rats.
Zhao L; Wu J; Wang Y; Yang J; Wei J; Gao W; Guo C
J Agric Food Chem; 2011 Feb; 59(4):1104-8. PubMed ID: 21250691
[TBL] [Abstract][Full Text] [Related]
11. Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer.
Novotný I; Dítĕ P; Dastych M; Záková A; Trna J; Novotná H; Nechutová H
Hepatogastroenterology; 2008; 55(85):1475-7. PubMed ID: 18795715
[TBL] [Abstract][Full Text] [Related]
12. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of blood plasma.
Rocha CM; Carrola J; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
J Proteome Res; 2011 Sep; 10(9):4314-24. PubMed ID: 21744875
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of pancreatic cancer via
Michálková L; Horník Š; Sýkora J; Habartová L; Setnička V
Analyst; 2018 Dec; 143(24):5974-5978. PubMed ID: 30270368
[TBL] [Abstract][Full Text] [Related]
14. Urine metabolic signature of pancreatic ductal adenocarcinoma by (1)h nuclear magnetic resonance: identification, mapping, and evolution.
Napoli C; Sperandio N; Lawlor RT; Scarpa A; Molinari H; Assfalg M
J Proteome Res; 2012 Feb; 11(2):1274-83. PubMed ID: 22066465
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis.
Chang MC; Chang YT; Su TC; Yang WS; Chen CL; Tien YW; Liang PC; Wei SC; Wong JM
Pancreas; 2007 Jul; 35(1):16-21. PubMed ID: 17575540
[TBL] [Abstract][Full Text] [Related]
16. The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer.
Park JK; Ryu JK; Yoon WJ; Lee SH; Lee GY; Jeong KS; Kim YT; Yoon YB
Pancreas; 2012 Jan; 41(1):95-101. PubMed ID: 21778928
[TBL] [Abstract][Full Text] [Related]
17. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
Mayerle J; Kalthoff H; Reszka R; Kamlage B; Peter E; Schniewind B; González Maldonado S; Pilarsky C; Heidecke CD; Schatz P; Distler M; Scheiber JA; Mahajan UM; Weiss FU; Grützmann R; Lerch MM
Gut; 2018 Jan; 67(1):128-137. PubMed ID: 28108468
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic analysis of polar metabolites in lipoprotein fractions identifies lipoprotein-specific metabolic profiles and their association with insulin resistance.
Hyötyläinen T; Mattila I; Wiedmer SK; Koivuniemi A; Taskinen MR; Yki-Järvinen H; Orešič M
Mol Biosyst; 2012 Oct; 8(10):2559-65. PubMed ID: 22722885
[TBL] [Abstract][Full Text] [Related]
19. Molecular angiogenesis profile as a tool to discriminate chronic pancreatitis (CP) from pancreatic cancer (PC).
Berindan-Neagoe I; Burz C; Balacescu O; Balacescu L; Seicean A; Cristea V; Irimie A
Pancreas; 2011 Apr; 40(3):482-3. PubMed ID: 21412121
[No Abstract] [Full Text] [Related]
20. [Metabonomic variation of esophageal cancer within different ethnic groups in Xinjiang, China].
Ayxiam H; Ma H; Ilyar S; Zhang LW; Ablizi A; Batur M; Lu XM
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):591-6. PubMed ID: 19954070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
